Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Immunologic complexity of lymphoblastic lymphoma.

Grogan T, Spier C, Wirt DP, Hicks MJ, Paquin M, Hutter J, Miller T, Rangel C, Richter L, Jones S.

Diagn Immunol. 1986;4(2):81-8.

PMID:
3086016
2.

Cell surface markers in leukemia: biological and clinical correlations.

Thiel E.

Crit Rev Oncol Hematol. 1985;2(3):209-60. Review.

PMID:
3013441
3.

[Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].

Ling JY, Sun XF, Yan SL, He LR, Zhen ZJ, Xia Y.

Ai Zheng. 2007 Apr;26(4):418-22. Chinese.

PMID:
17430665
4.

Antigenically defined subgroups of lymphoblastic lymphoma. Relationship to clinical presentation and biologic behavior.

Sheibani K, Nathwani BN, Winberg CD, Burke JS, Swartz WG, Blayney D, van de Velde S, Hill LR, Rappaport H.

Cancer. 1987 Jul 15;60(2):183-90.

5.

Surface immunoglobulin-positive lymphoblastic lymphoma. A report of three cases.

Stroup R, Sheibani K, Misset JL, Szekely AM, Tremblay G, Rappaport H.

Cancer. 1990 Jun 1;65(11):2559-63.

6.

Diversity of immunological phenotypes of lymphoblastic lymphoma.

Cossman J, Chused TM, Fisher RI, Magrath I, Bollum F, Jaffe ES.

Cancer Res. 1983 Sep;43(9):4486-90.

7.

Cutaneous involvement in lymphoblastic lymphoma.

Chimenti S, Fink-Puches R, Peris K, Pescarmona E, Pütz B, Kerl H, Cerroni L.

J Cutan Pathol. 1999 Sep;26(8):379-85.

PMID:
10551409
8.

Phenotypic analysis of acute lymphoblastic leukemia (ALL) cells which are classified as non-T non-B and negative for common ALL antigen.

Kita K, Nasu K, Kamesaki H, Doi S, Tezuka H, Tatsumi E, Fukuhara S, Nishikori M, Uchino H, Shirakawa S.

Blood. 1985 Jul;66(1):47-52.

9.

Peripheral T-cell lymphoma: aggressive disease with heterogeneous immunotypes.

Grogan TM, Fielder K, Rangel C, Jolley CJ, Wirt DP, Hicks MJ, Miller TP, Brooks R, Greenberg B, Jones S.

Am J Clin Pathol. 1985 Mar;83(3):279-88.

10.
11.

Antigenic phenotype of TdT-positive cells in human peripheral blood.

Bradstock KF, Kerr A, Bollum FJ.

Cell Immunol. 1985 Feb;90(2):590-8.

PMID:
3155660
12.

B-lymphocyte associated differentiation antigen expression by 'non-B, non-T' acute lymphoblastic leukemia.

Flug F, Dodson L, Wolff J, Guarini L, Rausen A, Wang CY, Knowles DM 2nd.

Leuk Res. 1985;9(8):1051-8.

PMID:
2931557
13.

Immunotopographic assessment of lymphoid and plasma cell malignancies in the bone marrow.

Kronland R, Grogan T, Spier C, Wirt D, Rangel C, Richter L, Durie B, Greenberg B, Miller T, Jones S.

Hum Pathol. 1985 Dec;16(12):1247-54.

PMID:
2933317
14.

Lymphoblastic lymphoma expressing natural killer cell-associated antigens: a clinicopathologic study of six cases.

Sheibani K, Winberg CD, Burke JS, Nathwani BN, Blayney DW, Van de Velde S, Swartz WG, Rappaport H.

Leuk Res. 1987;11(4):371-7.

PMID:
3104695
16.

A comprehensive immunotopographic map of human thymus.

Wirt DP, Grogan TM, Nagle RB, Copeland JG, Richter LC, Rangel CS, Schuchardt M, Fosse J, Layton JM.

J Histochem Cytochem. 1988 Jan;36(1):1-12.

PMID:
2961798
17.
18.

Immunologic classification of acute lymphoblastic leukemia.

Cabrera ME.

Am J Pediatr Hematol Oncol. 1990 Fall;12(3):283-91. Review.

PMID:
2240474
19.

Intermediate lymphocytic lymphoma: an immunohistologic study with comparison to other lymphocytic lymphomas.

Weisenburger DD, Linder J, Daley DT, Armitage JO.

Hum Pathol. 1987 Aug;18(8):781-90.

PMID:
3301625
20.

Diagnostic and prognostic value of monoclonal antibodies in immunophenotyping of T cell lymphomas.

Odermatt BF, Knecht H, Hagen MF, Fehr J, Rüttner JR.

Acta Haematol. 1987;77(2):72-7.

PMID:
3111143
Items per page

Supplemental Content

Support Center